http://rdf.ncbi.nlm.nih.gov/pubchem/patent/TW-201404394-A
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_10e4b1416c6e66e0ade5429212414964 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4704 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-21 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00 |
filingDate | 2012-10-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0da35f4b4303aae4dfc15407b0ce96c7 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a7218f0bbce89b435fe3e870f91c8b0b |
publicationDate | 2014-02-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | TW-201404394-A |
titleOfInvention | Treatment of multiple sclerosis with a combination of LAQUINIMOD and β-interferon |
abstract | The present invention provides a method of treating a patient suffering from multiple sclerosis or having a clinical single syndrome comprising administering to the patient laquinimod as an add-on therapy to interferon-β. Or in combination with interferon-β. The invention also provides a package and pharmaceutical composition comprising laquinimod and interferon-beta for treating a patient suffering from multiple sclerosis or having a clinical single syndrome. The invention also provides laquinimod as adjunctive therapy or in combination with interferon-beta for the treatment of patients with multiple sclerosis or clinically unique syndromes. The invention further provides the use of laquinimod and interferon-beta for the preparation of a combination for treating a patient suffering from multiple sclerosis or having a clinical single syndrome. |
priorityDate | 2012-07-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 433.